Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 341.1 million compared to CNY 234.53 million a year ago. Revenue was CNY 341.1 million compared to CNY 234.53 million a year ago.

Net income was CNY 85.13 million compared to CNY 50.98 million a year ago. Basic earnings per share from continuing operations was CNY 1.42 compared to CNY 0.85 a year ago. Diluted earnings per share from continuing operations was CNY 1.42 compared to CNY 0.85 a year ago.